The president and CEO of Harvard Pilgrim Health Care made perfectly clear who he thinks bears significant blame for health care spending that is growing faster than state policymakers would like.
A special commission studying health care pricing in Massachusetts discussed the roles employers and health plans should play in terms of narrowing the gap on cost of care.
Marlborough's RXi Pharmaceuticals Corporation has entered into an exclusive agreement to purchase Boston-based MirImmune Inc. and announced plans to raise funds for the purchase.
Under the advisement of the U.S. Food & Drug Administration, Biostage has decided to extend their animal testing of its Cellframe organ implants and push back its investigational new drug (IND) filing.
The state Department of Public Health has recommended approval of a $1 billion expansion at Boston Children's Hospital, a step that moves the controversial project closer to fruition.